top of page
Search
All Posts


Reducing barriers to biologic access may help more people with severe asthma achieve remission
Ecological analysis links easier access to biologic therapies with better asthma outcomes, including clinical remission Building on the GLEAM I study linking earlier identification and treatment of high-risk and severe asthma with greater likelihood of remission, the GLEAM II study reveals that patients in countries with fewer barriers to biologic access were significantly more likely to achieve clinical remission and other favourable asthma outcomes than those in countries w
Aug 113 min read


New RESA e-tool Enables Personalised Prediction of Severe Asthma Attacks
Researchers from the National University of Singapore and University of British Columbia have created a free online tool called the Risk of Exacerbation in Severe Asthma (RESA) e-tool to help clinicians estimate a person’s likelihood of having a serious asthma flare-up over the next 12 months. The work was recently published in The Journal of Allergy and Clinical Immunology: In Practice, entitled “Development and Validation of the Risk of Exacerbation in Severe Asthma (RESA)
May 283 min read


Asthma patients in Greece found to have fewer asthma exacerbations and steroid-related diseases compared to global patterns in new study from ISAR
Greek patients with severe asthma were found to have a notably lower asthma exacerbation rate compared with patients globally, while long-term oral corticosteroid (LTOCS) use, and importantly evidence of steroid-related disease, was substantially lower in Greece compared with Southern Europe and global rates. Differences in severe asthma characteristics, treatment patterns, and disease control between Greece, Southern Europe, and the global population have been identified in
May 202 min read


World Asthma Day 2026
On World Asthma Day 2026, we’re raising awareness of asthma- a condition affecting over 400 million people worldwide - and reflecting on the urgent need to rethink how we identify and manage its most serious forms. Severe asthma continues to place a significant burden on patients and healthcare systems globally. At Optimum Patient Care (OPC), we’re proud to lead the International Severe Asthma Registry (ISAR), a collaborative global platform advancing real-world research
May 51 min read
bottom of page
